5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.38▲ | 2.38▲ | 2.38▲ | 2.37▼ | 2.48▼ |
MA10 | 2.38▲ | 2.37▲ | 2.37▲ | 2.34▼ | 2.72▼ |
MA20 | 2.34▲ | 2.32▲ | 2.32▲ | 2.46▼ | 3.60▼ |
MA50 | 2.31▲ | 2.32▲ | 2.36▲ | 2.74▼ | 1.94▲ |
MA100 | 2.37▲ | 2.43▼ | 2.62▼ | 3.10▼ | N/A |
MA200 | 2.59▼ | 2.82▼ | 2.67▼ | 1.89▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.003▲ | 0.012▲ | 0.014▲ | 0.023▲ | -0.275▼ |
RSI | 59.941▲ | 58.210▲ | 55.868▲ | 40.705▼ | 47.844▼ |
STOCH | 58.333 | 76.667 | 76.667 | 54.207 | 10.954▼ |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -65.909 | -96.941▼ |
CCI | 104.762▲ | 86.603 | 88.923 | 7.291 | -71.606 |
Saturday, April 26, 2025 05:01 PM
Allurion Technologies Inc. (NYSE:ALUR – Get Free Report) was the recipient of a large decline in short interest during the month of April.As of April 15th, there was short interest totalling ...
|
Saturday, April 26, 2025 05:01 PM
Allurion Technologies Inc. (NYSE:ALUR – Get Free Report) was the recipient of a large decline in short interest during the month of April.As of April 15th, there was short interest totalling ...
|
Friday, April 25, 2025 09:00 AM
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, a swallowable and procedure-less ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 2.32 | 2.45 | 2.29 | 2.33 | 41,000 |
30/04/25 | 2.29 | 2.41 | 2.25 | 2.37 | 32,100 |
29/04/25 | 2.36 | 2.40 | 2.36 | 2.38 | 27,390 |
28/04/25 | 2.42 | 2.4425 | 2.34 | 2.36 | 17,445 |
25/04/25 | 2.28 | 2.4399 | 2.28 | 2.40 | 45,376 |
24/04/25 | 2.28 | 2.362 | 2.26 | 2.33 | 31,600 |
23/04/25 | 2.22 | 2.3993 | 2.22 | 2.27 | 31,479 |
22/04/25 | 2.30 | 2.34 | 2.20 | 2.29 | 80,855 |
21/04/25 | 2.27 | 2.305 | 2.20 | 2.29 | 63,366 |
17/04/25 | 2.31 | 2.415 | 2.21 | 2.34 | 59,557 |
|
|
||||
|
|
||||
|
|